All Disease Treatment & Prevention articles – Page 17
-
NewsAndelyn Biosciences launches LVV Curator® Platform
Andelyn Biosciences has announced the launch of its LVV Curator® Platform, a standardized lentiviral vector (LVV) manufacturing solution built on the same proven modular approach that supports clinical and commercial adeno-associated virus (AAV) programs.
-
NewsCommentary: Dengue viral infection and associated liver disease
A new commentary highlights the time course of serological and liver enzyme elevations in mild versus severe dengue, emphasizes early recognition of progression to acute liver failure, and reviews current vaccination and prevention strategies.
-
NewsFDA approves early warning system for sepsis
An early warning system for sepsis, one of the deadliest infections for hospital patients, has been approved for use by the FDA, one of the first AI-based medical tools to get clearance. The tool detects sepsis hours faster than doctors and has reduced deaths by nearly 20%.
-
NewsGut microbiota plays a role in metabolic health after bariatric surgery
Changes in gut microbiota after bariatric surgery are strongly linked to altered metabolic health and sustained improvement in type 2 diabetes. A study shows changes in gut bacterial composition and function are associated with metabolic improvements, including insulin release and blood sugar control.
-
NewsGlobal outbreaks may fuel violence against women — but most cases go unmeasured
Violence against women and girls may increase during infectious disease outbreaks — as economic strain, isolation and disrupted services reshape daily life — yet those impacts remain largely unmeasured, according to a new study.
-
NewsScientists discover how gut bacteria toxin invades colon cells to trigger cancer
A common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that damages the lining of the colon. Researchers have now shown that the B. fragilis toxin BFT must first bind host receptor claudin-4 before it can cause damage.
-
NewsLong-term dynamic virological response patterns and clinical outcomes in hepatitis B virus-related cirrhosis
The long-term clinical outcomes of patients with hepatitis B virus (HBV)-related cirrhosis receiving nucleos(t)ide analog (NA) therapy according to virological response patterns remain inadequately defined. A new study aimed to investigate the association between virological response patterns and clinical outcomes.
-
NewsHead impacts associated with altered gut microbiome in football players
Non-concussive head impacts—hits to the head that don’t cause clinically detectable symptoms—are correlated with subsequent changes to the gut microbiome in a small sample of US collegiate football players, according to a new study.
-
NewsReview finds no direct link between aluminium adjuvanted vaccines and serious or long term health conditions
Current evidence does not support direct (causal) associations between aluminium adjuvanted vaccines and serious or long term health outcomes, including autism, diabetes and asthma, finds a review of the latest data.
-
NewsCaesarean birth: sex-specific effects on the microbiota
A research team investigating microbial colonisation in early life set out to understand how delivery mode and sex interact over the course of development, and whether this interaction could affect susceptibility to intestinal diseases such as colitis in adulthood.
-
NewsWhy feeling sick may be important for surviving infection
In a new perspective, scientists propose a different way of thinking about sickness symptoms: what if these behaviors are part of an integrated immune strategy that operates across scales — from individual cells to tissues and organs, to the whole organism — and helps promote survival?
-
NewsNovel wheat hybrids increase resistance to major fungal disease by up to 70%
A new experimental study has identified a novel genetic locus in a common agricultural weed that provides significant resistance to Fusarium Head Blight (FHB) and has now been successfully transferred into wheat to produce FHB resistant hybrids.
-
NewsDisease-causing pathogen rewires gut metabolism to secure nutrients for growth
Enterotoxigenic Bacteroides fragilis (ETBF), which causes diarrhea and has been implicated in colitis and colorectal cancer, uses a toxin it produces to reprogram intestinal cell metabolism and generate conditions that support its growth.
-
NewsFrom gut to brain: scientists engineer bacteria to treat severe liver-related brain dysfunction
In vivo studies showed that programmable “living medicines” could reduce brain toxins and prevent neurological symptoms of hepatic encephalopathy, offering distinct advantages over a widely prescribed antibiotic.
-
NewsScientists source anti-cancer treatment in bacteria
Researchers have developed an anti-cancer therapy inspired by bacteria found in cancer tumors. The therapy is made from a fragment of a bacterial protein, a peptide called aurB. In cancer tumors in the animal models, aurB prevented energy production in the tumor cells’ mitochondria, essentially cutting off the tumor’s fuel.
-
NewsLifestyle, diet, and clinical factors shape the gut microbiome in cancer patients
Lifestyle factors, such as physical activity and dietary modifications can beneficially modulate the gut microbiome of cancer patients - however their effects are often shaped by non-modifiable variables.
-
NewsNew study suggests reduced newborn hepatitis B vaccination coverage may increase infant infections
Researchers found that lower vaccination coverage among infants born to unscreened mothers was associated with a substantial increase in HBV infections.
-
NewsNew cellular target prevents hepatitis E infection
To replicate, a virus must first enter a host cell. In a recent study, the researchers specifically investigated host cell processes required for successful HEV infection. In doing so, they identified the enzyme PIKfyve as a crucial factor for viral entry.
-
NewsAssociation of changes in portal insulin with immunometabolism during and after hepatitis C virus infection
A new study aims to investigate the relationship between insulin, the gut-liver axis, and immunometabolic changes in patients with hepatitis C virus. Lower portal insulin during HCVi is associated with changes consistent with altered pancreatic insulin secretion and decreased hepatic insulin extraction.
-
NewsThe brain–gut health initiative: A pioneering effort in psychiatric research
Researchers analyze brain imaging data, microbiome profiles, and clinical assessments to identify biomarkers for precision mental healthcare. The Brain–Gut Health Initiative is an ongoing long-term clinical study designed to investigate how interactions between the brain and gut microbiome contribute to psychiatric disorders.